{
    "Trade/Device Name(s)": [
        "Randox Aldolase Calibration Serum"
    ],
    "Submitter Information": "Randox Laboratories Limited",
    "510(k) Number": "K142181",
    "Predicate Device Reference 510(k) Number(s)": [
        "K053153"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JIT"
    ],
    "Summary Letter Date": "August 6, 2014",
    "Summary Letter Received Date": "August 8, 2014",
    "Submission Date": "September 11, 2014",
    "Regulation Number(s)": [
        "21 CFR 862.1150"
    ],
    "Regulation Name(s)": [
        "Calibrator, Secondary"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Aldolase"
    ],
    "Specimen Type(s)": [
        "Human Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Randox RX Daytona",
        "Beckman Coulter AU640"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Calibrator",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for Randox Aldolase Calibration Serum, a lyophilized human serum calibrator for Aldolase assays on specified clinical chemistry analyzers",
    "Indications for Use Summary": "Intended for in vitro diagnostic use in the calibration of Aldolase on the Randox RX Daytona and Beckman Coulter AU640 systems; prescription use only",
    "fda_folder": "Clinical Chemistry"
}